Angiotensin II and its role in tubular epithelial to mesenchymal transition associated with chronic kidney disease

Cells Tissues Organs

Volumn 193, Issue 1-2, 2010, Pages 74-84

  Burns, W C ^a   Thomas, M C ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Angiotensin II; Chronic kidney disease; Epithelial to mesenchymal transition; Renal fibrosis; Renin angiotensin system

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; ADVANCED GLYCATION END PRODUCT; ANGIOTENSIN II; CONNECTIVE TISSUE GROWTH FACTOR; PYRIDOXAMINE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG INHIBITION; DRUG POTENTIATION; EPITHELIAL MESENCHYMAL TRANSITION; FIBROGENESIS; HUMAN; KIDNEY EPITHELIUM; KIDNEY HYPERTROPHY; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION;

ANGIOTENSIN II; ANIMALS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; KIDNEY DISEASES; RENIN-ANGIOTENSIN SYSTEM;

EID: 78650510392     PISSN: 14226405     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320359     Document Type: Article

References (88)

1. Arendshorst, W. J., K. Brannstrom, X. Ruan (1999) Actions of angiotensin II on the renal microvasculature. J Am Soc Nephrol 10 (suppl 11): S149-S161.
2. Asano, M., Y. Fujita, Y. Ueda, D. Suzuki, T. Miyata, H. Sakai, A. Saito (2002) Renal proximal tubular metabolism of protein-linked pentosidine, an advanced glycation end product. Nephron 91:688-694.
3. Bhowmick, N. A., M. Ghiassi, A. Bakin, M. Aakre, C. A. Lundquist, M. E. Engel, C. L. Arteaga, H. L. Moses (2001) Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 12:27-36.
4. Bolos, V., H. Peinado, M. A. Perez-Moreno, M. F. Fraga, M. Esteller, A. Cano (2003) The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci 116:499-511.
5. Bondi, C. D., N. Manickam, D. Y. Lee, K. Block, Y. Gorin, H. E. Abboud, J. L. Barnes (2010) NAD (P) H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts. J Am Soc Nephrol 21:93-102.
6. Border, W., A. N. A. Noble (1997) TGF-beta in kidney fibrosis: a target for gene therapy. Kidney Int 51:1388-1396.
7. Border, W., A. N. A. Noble (1998) Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. Hypertension 31:181-188.
8. Bravo, J., Y. Quiroz, H. Pons, G. Parra, J. Herrera-Acosta, R. J. Johnson, B. Rodriguez-Iturbe (2003) Vimentin and heat shock protein expression are induced in the kidney by angiotensin and by nitric oxide inhibition. Kidney Int Suppl 86: S46-S51.
9. Burch, M. L., M. L. Ballinger, S. N. Yang, R. Getachew, C. Itman, K. Loveland, N. Osman, P. J. Little (2010) Thrombin stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by PAR-1 transactivation of the transforming growth factor beta type I receptor. J Biol Chem 285:26798-26805.
10. Burns, W. C., E. Velkoska, R. G. Dean, L. M. Burrell, M. C. Thomas (2010) Angiotensin II mediates epithelial-to-mesenchymal transformation in tubular cells by Ang1-7/Mas-1 dependent pathways. Am J Physiol Renal Physiol, Epub ahead of print.
11. Carvajal, G., J. Rodriguez-Vita, R. Rodrigues-Diez, E. Sanchez-Lopez, M. Ruperez, C. Cartier, V. Esteban, A. Ortiz, J. Egido, S. A. Mezzano, M. Ruiz-Ortega (2008) Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation. Kidney Int 74:585-595.
12. Chen, L., B. C. Liu, X. L. Zhang, J. D. Zhang, H. Liu, M. X. Li (2006) Influence of connective tissue growth factor antisense oligonucleotide on angiotensin II-induced epithelial mesenchymal transition in HK2 cells. Acta Pharmacol Sin 27:1029-1036.
13. Cheng, S., A. S. Pollock, R. Ma himkar, J. L. Olson, D. H. Lovett (2006) Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury. FASEB J 20:1898-1900.
14. Counihan, N. A., L. M. Daniel, J. Chojnacki, D. A. Anderson (2006) Infrared fluorescent immunofocus assay (IR-FIFA) for the quantitation of non-cytopathic and minimally cytopathic viruses. J Virol Methods 133:62-69.
15. Dzau, V. J. (1988) Circulating versus local reninangiotensin system in cardiovascular homeostasis. Circulation 77: I4-I13.
16. Egido, J. (1996) Vasoactive hormones and renal sclerosis. Kidney Int 49:578-597.
17. English, V., L. Cassis (1999) Facilitation of sympathetic neurotransmission contributes to angiotensin regulation of body weight. J Neural Transm 106:631-644.
18. Erdos, E. G. (1976) Conversion of angi otensin I to angiotensin II. Am J Med 60:749-759.
19. Esteban, V., O. Lorenzo, M. Ruperez, Y. Suzuki, S. Mezzano, J. Blanco, M. Kretzler, T. Sugaya, J. Egido, M. Ruiz-Ortega (2004) Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inf lammatory response in unilateral ureteral obstruction. J Am Soc Nephrol 15:1514-1529.
20. Fan, Y. Y., R. Baba, Y. Nagai, A. Miyatake, N. Hosomi, S. Kimura, G. P. Sun, M. Kohno, M. Fujita, Y. Abe, A. Nishiyama (2006) Augmentation of intrarenal angiotensin II levels in uninephrectomized aldosterone/salt-treated hypertensive rats; renoprotective effects of an ultrahigh dose of olmesartan. Hypertens Res 29:169-178.
21. Fan, J. M., X. R. Huang, Y. Y. Ng, D. J. Nikolic-Paterson, W. Mu, R. C. Atkins, H. Y. Lan (2001) Interleukin-1 induces tubular epithelialmyofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro. Am J Kidney Dis 37:820-831.
22. Forbes, J. M., M. E. Cooper, V. Thallas, W. C. Burns, M. C. Thomas, G. C. Brammar, F. Lee, S. L. Grant, L. M. Burrell, G. Jerums, T. M. Osicka (2002) Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. Diabetes 51:3274-3282.
23. Fujisawa, T., H. Ikegami, Y. Kawaguchi, Y. Hamada, H. Ueda, M. Shintani, M. Fukuda, T. Ogihara (1998) Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia 41:47-53.
24. Garber, S. L., Y. Mirochnik, S. S. Desai, J. A. Arruda, G. Dunea (1998) Angiotensin-converting enzyme inhibition reduces the effect of bromoethylamine-induced papillary necrosis and renal fibrosis. J Am Soc Nephrol 9:1052-1059.
25. Gilbert, R. E., L. L. Wu, D. J. Kelly, A. Cox, J. L. Wilkinson-Berka, C. I. Johnston, M. E. Cooper (1999) Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis. Am J Pathol 155:429-440.
26. Griendling, K. K., D. Sorescu, M. Ushio-Fukai (2000) NAD (P) H oxidase: role in cardiovascular biology and disease. Circ Res 86:494-501.
27. Hisada, Y., T. Sugaya, M. Yamanouchi, H. Uchida, H. Fujimura, H. Sakurai, A. Fukamizu, K. Murakami (1999) Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J Clin Invest 103:627-635.
28. Husain, A., M. Li, R. M. Graham (2003) Do studies with ACE N-and C-domain-selective inhibitors provide evidence for a non-ACE, non-chymase angiotensin II-forming pathway? Circ Res 93:91-93.
29. Hussain, A., A. W. Wyatt, K. Wang, M. Bhandaru, R. Biswas, D. Avram, M. Foller, R. Rexhepaj, B. Friedrich, S. Ullrich, G. Muller, D. Kuhl, T. Risler, F. Lang (2008) SGK1-dependent upregulation of connective tissue growth factor by angiotensin II. Kidney Blood Press Res 31:80-86.
30. Ishidoya, S., J. Morrissey, R. McCracken, A. Reyes, S. Klahr (1995) Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 47:1285-1294.
31. Iwano, M., D. Plieth, T. M. Danoff, C. Xue, H. Okada, E. G. Neilson (2002) Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110:341-350.
32. Johnson, R. J., C. E. Alpers, A. Yoshimura, D. Lombardi, P. Pritzl, J. Floege, S. M. Schwartz (1992) Renal injury from angiotensin II-mediated hypertension. Hypertension 19:464-474.
33. Kagami, S., W. A. Border, D. E. Miller, N. A. Noble (1994) Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437.
34. Kalluri, R. E., G. Neilson (2003) Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112:1776-1784.
35. Kelly, D. J., J. L. Wilkinson-Berka, T. J. Allen, M. E. Cooper, S. L. Skinner (1998) A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2) 27 rat (TGR). Kidney Int 54:343-352.
36. Klahr, S., J. Morrissey (1998) Angiotensin II and gene expression in the kidney. Am J Kidney Dis 31:171-176.
37. Kokkonen, J. O., K. A. Lindstedt, P. T. Kovanen (2003). Role for chymase in heart failure: angiotensin II-dependent or-independent mechanisms? Circulation 107:2522-2524.
38. Kolosionek, E., R. Savai, H. A. Ghofrani, N. Weissmann, A. Guenther, F. Grimminger, W. Seeger, G. A. Banat, R. T. Schermuly, S. S. Pullamsetti (2009) Expression and activity of phosphodiesterase isoforms during epithelial mesenchymal transition: the role of phosphodiesterase 4. Mol Biol Cell 20:4751-4765.
39. Lafayette, R. A. (2000) How does knocking out angiotensin II activity reduce renal injury in mice? Am J Kidney Dis 35:166-172.
40. Lan, H. Y. (2003) Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells. Curr Opin Nephrol Hypertens 12:25-29.
41. Lassila, M., M. E. Cooper, K. Jandeleit-Dahm (2004) Antiproteinuric effect of RAS blockade: new mechanisms. Curr Hypertens Rep 6:383-392.
42. Lavoie, J. L. C., D. Sigmund (2003) Minireview: overview of the renin-angiotensin system-an endocrine and paracrine system. Endocrinology 144:2179-2183.
43. Li, J., X. Qu, J. F. Bertram (2009) Endothelialmyofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. Am J Pathol 175:1380-1388.
44. Liu, N., S. Shimizu, T. Ito-Ihara, K. Takagi, T. Kita, T. Ono (2007) Angiotensin II receptor blockade ameliorates mesangioproliferative glomerulonephritis in rats through suppression of CTGF and PAI-1, independently of the coagulation system. Nephron Exp Nephrol 105: e65-e74.
45. Liu, Y. (2004) Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 15:1-12.
46. Manucha, W., L. Carrizo, C. Ruete, H. Molina, P. Valles (2005) Angiotensin II type I antagonist on oxidative stress and heat shock protein 70 (HSP 70) expression in obstructive nephropat hy. Cel l Mol Biol (Noisy-le-grand) 51:547-555.
47. Masszi, A., C. Di Ciano, G. Sirokmany, W. T. Arthur, O. D. Rotstein, J. Wang, C. A. McCulloch, L. Rosivall, I. Mucsi, A. Kapus (2003) Central role for Rho in TGF-beta1-induced alpha-smooth muscle actin expression during epithelial-mesenchymal transition. Am J Physiol Renal Physiol 284: F911-F924.
48. McLennan, S. V., D. J. Kelly, A. J. Cox, Z. Cao, J. G. Lyons, D. K. Yue, R. E. Gilbert (2002) Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases. Diabetologia 45:268-275.
49. Mezzano, S. A., M. Ruiz-Ortega, J. Egido (2001) Angiotensin II and renal fibrosis. Hypertension 38:635-638.
50. Morrissey, J., J. S. Klahr (1999) Effect of AT2 receptor blockade on the pathogenesis of renal fibrosis. Am J Physiol 276: F39-F45.
51. Nagahama, T., K. Hayashi, Y. Ozawa, T. Takenaka, T. Saruta (2000) Role of protein kinase C in angiotensin II-induced constriction of renal microvessels. Kidney Int 57:215-223.
52. Navar, L. G., E. W. Inscho, S. A. Majid, J. D. Imig, L. M. Harrison-Bernard, K. D. Mitchell (1996) Paracrine regulation of the renal microcirculation. Physiol Rev 76:425-536.
53. Nishiyama, A., D. M. Seth, L. G. Navar (2002) Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats. Hypertension 39:129-134.
54. Ohta, K., S. Kim, A. Hamaguchi, T. Yukimura, K. Miura, K. Takaori, H. Iwao (1994) Role of angiotensin II in extracellular matrix and transforming growth factor-beta 1 expression in hypertensive rats. Eur J Pharmacol 269:115-119.
55. Oldfield, M. D., L. A. Bach, J. M. Forbes, D. Nikolic-Paterson, A. McRobert, V. Thallas, R. C. Atkins, T. Osicka, G. Jerums, M. E. Cooper (2001) Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest 108:1853-1863.
56. Pagtalunan, M. E., J. L. Olson, T. W. Meyer (2000) Contribution of angiotensin II to late renal injury after acute ischemia. J Am Soc Nephrol 11:1278-1286.
57. Peters, H., W. A. Border, N. A. Noble (1998) Targeting TGF-beta overexpression in renal disease: maximizing the antifibrotic action of angiotensin II blockade. Kidney Int 54:1570-1580.
58. Pichler, R. H., N. Franceschini, B. A. Young, C. Hugo, T. F. Andoh, E. A. Burdmann, S. J. Shankland, C. E. Alpers, W. M. Bennett, W. G. Couser, et al. (1995) Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin. J Am Soc Nephrol 6:1186-1196.
59. Rastaldi, M. P., F. Ferrario, L. Giardino, G. Dell'Antonio, C. Grillo, P. Grillo, F. Strutz, G. A. Muller, G. Colasanti, G. D'Amico (2002) Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int 62:137-146.
60. Rhyu, D. Y., Y. Yang, H. Ha, G. T. Lee, J. S. Song, S. T. Uh, H. B. Lee (2005) Role of reac tive ox ygen species in TGF-beta1-induced mitogenactivated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol 16:667-675.
61. Rodrigues-Diez, R., G. Carvajal-Gonzalez, E. Sanchez-Lopez, J. Rodriguez-Vita, R. Rodrigues Diez, R. Selgas, A. Ortiz, J. Egido, S. Mezzano, M. Ruiz-Or tega (2008) Pharmacological modulation of epithelial mesenchymal transition caused by angiotensin II. Role of ROCK and MAPK pathways. Pharm Res 25:2447-2461.
62. Rodriguez-Vita, J., E. Sanchez-Lopez, V. Esteban, M. Ruperez, J. Egido, M. Ruiz-Ortega (2005) Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism. Circulation 111:2509-2517.
63. Ruiz-Ortega, M., M. J. Egido (1997) Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney Int 52:1497-1510.
64. Ruiz-Ortega, M., O. Lorenzo, M. Ruperez, S. Konig, B. Wittig, J. Egido (2000) Angiotensin II activates nuclear transcription factor kappaB through AT (1) and AT (2) in vascular smooth muscle cells: molecular mechanisms. Circ Res 86:1266-1272.
65. Ruiz-Ortega, M., M. Ruperez, V. Esteban, J. Egido (2003) Molecular mechanisms of angiotensin II-induced vascular injury. Curr Hypertens Rep 5:73-79.
66. Sadoshima, J. (2000) Cytokine actions of angiotensin II. Circ Res 86:1187-1189.
67. Schanstra, J. P., E. Neau, P. Drogoz, M. A. Arevalo Gomez, J. M. Lopez Novoa, D. Calise, C. Pecher, M. Bader, J. P. Girolami, J. L. Bascands (2002) In vivo bradykinin B2 receptor activation reduces renal fibrosis. J Clin Invest 110:371-379.
68. Seshiah, P. N., D. S. Weber, P. Rocic, L. Valppu, Y. Taniyama, K. K. Griendling (2002) Angiotensin II stimulation of NAD (P) H oxidase activity: upstream mediators. Circ Res 91:406-413.
69. Shihab, F. S., W. M. Bennett, A. M. Tanner, T. F. Andoh (1997) Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy. Kidney Int 52:660-673.
70. Shirazi, M., A. Noorafshan, M. A. Bahri, N. Tanideh (2007) Captopril reduces interstitial renal fibrosis and preserves more normal renal tubules in neonatal dogs with partial urethral obstruction: a preliminary study. Urol Int 78:173-177.
71. Singh, R., N. Alavi, A. K. Singh, D. J. Leehey (1999) Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation. Diabetes 48:2066-2073.
72. Song, J. (2007) EMT or apoptosis: a decision for TGF-beta. Cell Res 17:289-290.
73. Song, J. H., S. H. Cha, H. J. Lee, S. W. Lee, G. H. Park, M. J. Kim (2006) Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advancedkidney disease. Neph rol Dial Transplant 21:683-689.
74. Strutz, F., G. A. Muller, E. G. Neilson (1996) Transdifferentiation: a new angle on renal fibrosis. Exp Nephrol 4:267-270.
75. Thomas, M. C., C. Tikellis, W. M. Burns, K. Bialkowski, Z. Cao, M. T. Coughlan, K. Jandeleit-Dahm, M. E. Cooper, J. M. Forbes (2005). Interactions between renin angiotensin system and advanced glycation in the kidney. J Am Soc Nephrol 16:2976-2984.
76. Touyz, R. M., X. Chen, F. Tabet, G. Yao, G. He, M. T. Quinn, P. J. Pagano, E. L. Schiffrin (2002) Expression of a functionally active gp91phox-containing neutrophil-type NAD (P) H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res 90:1205-1213.
77. Wilkinson-Berka, J. L., D. J. Kelly, S. M. Koerner, K. Jaworski, B. Davis, V. Thallas, M. E. Cooper (2002) ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2) 27 rat. Diabetes 51:3283-3289.
78. Wolf, G. (2001) Angiotensin II as a renal growth factor. Contrib Nephrol 92-110.
79. Wolf, G., E. Mueller, R. A. Stahl, F. N. Ziyadeh (1993) Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta. J Clin Invest 92:1366-1372.
80. Wolf, G. E., G. Neilson (1996) From converting enzyme inhibition to angiotensin II receptor blockade: new insight on angiotensin II receptor subtypes in the kidney. Exp Nephrol 4 (suppl 1):8-19.
81. Wolf, G. F., N. Ziyadeh (1997) Renal tubular hypertrophy induced by angiotensin II. Semin Nephrol 17:448-454.
82. Yang, J., C. Dai, Y. Liu (2002) Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice. J Am Soc Nephrol 13:2464-2477.
83. Yang, J., J. Y. Liu (2001) Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 159:1465-1475.
84. Yoo, K. H., B. A. Thornhill, J. T. Wolstenholme, R. L. Chevalier (1998) Tissue-specific regulation of growth factors and clusterin by angiotensin II. Am J Hypertens 11:715-722.
85. Yu, X. Q., L. L. Wu, X. R. Huang, N. Yang, R. E. Gilbert, M. E. Cooper, R. J. Johnson, K. N. Lai, H. Y. Lan (2000) Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin II. Kidney Int 58:1469-1480.
86. Zatz, R., B. R. Dunn, T. W. Meyer, S. Anderson, H. G. Rennke, B. M. Brenner (1986) Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925-1930.
87. Zimmerman, M. C., E. Lazartigues, J. A. Lang, P. Sinnayah, I. M. Ahmad, D. R. Spitz, R. L. Davisson (2002) Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res 91:1038-1045.
88. Zoja, C., R. Donadelli, D. Corna, D. Testa, D. Facchinet ti, R. Maffi, E. Luzzana, V. Colosio, T. Bertani, G. Remuzzi (1997) The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist. Am J Kidney Dis 29:254-264.